Serum lnc34a is a potential prediction biomarker for bone metastasis in hepatocellular carcinoma patients

por Zhang, Li, Niu, Hao, Yang, Ping, Ma, Jie, Yuan, Bao-Ying, Zeng, Zhao-Chong, Xiang, Zuo-Lin
Publicado 2021

Pre/Post-Treatment Dynamic of Inflammatory Markers Has Prognostic Value in Patients with Small Hepatocellular Carcinoma Managed by Stereotactic Body Radiation Therapy

por Zhuang, Yuan, Yuan, Bao-Ying, Hu, Yong, Chen, Gen-Wen, Zhang, Li, Zhao, Xiao-Mei, Chen, Yi-Xing, Zeng, Zhao-Chong
Publicado 2019

Association Between Circulating Lymphocyte Populations and Outcome After Stereotactic Body Radiation Therapy in Patients With Hepatocellular Carcinoma

por Zhuang, Yuan, Yuan, Bao-ying, Chen, Gen-wen, Zhao, Xiao-mei, Hu, Yong, Zhu, Wen-chao, Zeng, Zhao-chong, Chen, Yi-xing
Publicado 2019

The molecular mechanism of LncRNA34a-mediated regulation of bone metastasis in hepatocellular carcinoma

por Zhang, Li, Niu, Hao, Ma, Jie, Yuan, Bao-Ying, Chen, Yu-Han, Zhuang, Yuan, Chen, Gen-Wen, Zeng, Zhao-Chong, Xiang, Zuo-Lin
Publicado 2019

A nomogram to predict prognosis of patients with unresected hepatocellular carcinoma undergoing radiotherapy: a population-based study

por Zhang, Li, Yan, Li, Niu, Hao, Ma, Jie, Yuan, Bao-Ying, Chen, Yu-Han, Zhuang, Yuan, Hu, Yong, Zeng, Zhao-Chong, Xiang, Zuo-Lin
Publicado 2019